Casticin suppresses self-renewal related stemness via miR-342-3p-mediated FoxM1 downregulation in cervical cancer cells.
Xiaozheng CaoXiping HuXiaona XuWeiting ZhuQinghua LinYijie LeWeifeng FengYong XuShaoqiang LinPublished in: Phytomedicine : international journal of phytotherapy and phytopharmacology (2024)
CAS suppresses self-renewal-associated stemness by targeting FOXM1 via miR-342-3p upregulation. These findings suggest CAS is promising as a novel therapeutic candidate in CC.